OBJECTIVE: To review the literature examining the use of methylxanthines in
the treatment of anaphylaxis.
DATA SOURCE: A MEDLINE search (January 1966-December 1998) was performed us
ing the terms aminophylline, theophylline, and anaphylaxis.
STUDY SELECTION AND DATA EXTRACTION: Articles discussing methylxanthine use
in anaphylaxis were independently examined by each author. Additional info
rmation was obtained through the references of these articles. Articles not
written in English were excluded.
DATA SYNTHESIS: No human studies were identified. Limited published data we
re found in animal models of anaphylaxis.
CONCLUSIONS: Safer agents with proven efficacy exist for the treatment of b
ronchoconstriction in anaphylaxis. Until data are available in humans, meth
ylxanthines should not be recommended in the treatment of anaphylactic reac
tions.